Filters:
797 Projects | 548 Researchers | $376,488,329 Invested
2025
Emory University
Thomas Kukar, PhD
Development of a granulin biologic to treat progranulin deficient FTD.
2025
Circular Genomics Inc
Nikolaos Mellios, MD, PhD
Alzheimer’s disease specificity and sensitivity analyses of circRNA blood biomarkers
2025
University of Gothenburg
Henrik Zetterberg, MD, PhD
Quality control (QC) program for CSF and plasma biomarkers for Alzheimer’s disease
2025
Sunbird Bio
Mario Morken, MS/MBA
Proof-of-Principal clinical study for blood based extracellular vesicle bound biomarker signatures quantifying brain alpha synuclein aggregation state
2025
Banner Health
Nicholas Ashton, PhD
Determining %p-tau217 and MTBR-243 by immunoassay
2024
MoCA Cognition
Ziad Nasreddine
Scientific validation of a digital MoCA for use in the general practice
2024
Johns Hopkins University
Philip Wong, PhD
Develop a diagnostic biomarker for frontotemporal dementia.
2024
Alamar Biosciences
Xiao-Jun Ma, PhD
Development of ARGO DX™ for a new generation of blood-based diagnostics for Alzheimer’s disease and related neurodegenerative diseases
2024
Polku Therapeutics
Timo Myöhänen, PhD
Novel prolyl oligopeptidase ligands to target Tau in frontotemporal dementia and other tauopathies
2024
Transposon Therapeutics
Andrew Satlin, MD
A Phase 2 Clinical Trial to Study the Effect of TPN-101, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with Alzheimer's Disease